Strides Pharma Science Ltd.

NSE: STAR | BSE: 532531

Strong Performer, Under Radar

Download real time

903.65 6.05 (0.67%)

76.13% Gain from 52W Low

250.9K

NSE+BSE Volume

NSE 20 Mar, 2026 3:31 PM (IST)

Acquisition

Strides Pharma to acquire a portfolio of branded generic products from Sandoz AG for $12 million See details

Strides Pharma Earnings/Conference Calls

Strides Pharma earnings concalls and investor presentations

Is Strides Pharma Science Ltd. worth buying?

493 Votes:

Buy 78.9%

Sell 11.76%

Hold 9.33%

RESEARCH REPORTS

Accumulate SEE REPORTS >

Buy SEE REPORTS >